{"id":"albendazole-and-praziquantel","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL976","moleculeType":"Small molecule","molecularWeight":"312.41"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Albendazole inhibits β-tubulin polymerization in helminth microtubules, preventing glucose uptake and energy production. Praziquantel increases cell membrane permeability to calcium in trematodes and cestodes, causing muscle contraction and paralysis. Together, they provide broad-spectrum activity against multiple parasitic worm species.","oneSentence":"Albendazole and praziquantel are anthelmintic agents that disrupt microtubule formation and calcium homeostasis in parasitic worms, leading to their paralysis and death.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:20:41.852Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Helminthic infections (roundworms, tapeworms, flukes)"},{"name":"Polyparasitic infections"}]},"trialDetails":[{"nctId":"NCT07074444","phase":"PHASE4","title":"Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel","status":"RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2025-07-22","conditions":"Clonorchiasis","enrollment":318},{"nctId":"NCT05323396","phase":"NA","title":"HIV And Parasitic Infection (HAPI) Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-05-02","conditions":"HIV Coinfection","enrollment":120},{"nctId":"NCT06565507","phase":"PHASE2, PHASE3","title":"Oxfendazole in Mild Parenchymal Brain Cysticercosis","status":"NOT_YET_RECRUITING","sponsor":"Universidad Peruana Cayetano Heredia","startDate":"2024-12-15","conditions":"Brain Cysticercosis","enrollment":544},{"nctId":"NCT06376396","phase":"PHASE4","title":"Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis","status":"NOT_YET_RECRUITING","sponsor":"R-Evolution Worldwide S.r.l. Impresa Sociale","startDate":"2024-06","conditions":"Neurocysticercosis","enrollment":300},{"nctId":"NCT06182176","phase":"NA","title":"Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2024-05-27","conditions":"Malaria, Soil Transmitted Helminths, Schistosomiasis","enrollment":1200},{"nctId":"NCT02947581","phase":"PHASE3","title":"Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)","status":"TERMINATED","sponsor":"Universidad Peruana Cayetano Heredia","startDate":"2016-11-14","conditions":"Neurocysticercosis","enrollment":107},{"nctId":"NCT05354258","phase":"NA","title":"Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2022-06-16","conditions":"Malaria, Soil Transmitted Helminths, Schistosomiasis","enrollment":600},{"nctId":"NCT02366884","phase":"PHASE2","title":"Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)","status":"UNKNOWN","sponsor":"Dr. Frank Arguello Cancer Clinic","startDate":"2011-07-26","conditions":"Neoplasms","enrollment":250},{"nctId":"NCT00441285","phase":"PHASE2, PHASE3","title":"Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)","status":"COMPLETED","sponsor":"Universidad Peruana Cayetano Heredia","startDate":"2010-01","conditions":"Neurocysticercosis, Epilepsy","enrollment":156},{"nctId":"NCT00507221","phase":"NA","title":"Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression","status":"COMPLETED","sponsor":"University of Washington","startDate":"2008-02","conditions":"HIV Infections, Helminthiasis","enrollment":948},{"nctId":"NCT00347113","phase":"NA","title":"Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanzania","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","startDate":"2006-07","conditions":"Anaemia, Malaria, Hepatosplenomegaly","enrollment":620},{"nctId":"NCT01722539","phase":"PHASE3","title":"Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren","status":"COMPLETED","sponsor":"Universiteit Antwerpen","startDate":"2012-11","conditions":"Healthy","enrollment":616},{"nctId":"NCT01541631","phase":"NA","title":"A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes","status":"UNKNOWN","sponsor":"Catholic University of Health and Allied Sciences","startDate":"2012-05","conditions":"Anemia, Intestinal Helminthiasis, Intestinal Schistosomiasis","enrollment":2000},{"nctId":"NCT01459146","phase":"PHASE4","title":"Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana","status":"UNKNOWN","sponsor":"Navrongo Health Research Centre, Ghana","startDate":"2010-12","conditions":"Malaria, Schistosomiasis, Helminthiasis","enrollment":345},{"nctId":"NCT00817713","phase":"NA","title":"Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?","status":"TERMINATED","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2009-01","conditions":"HIV Infections, Helminthiasis","enrollment":295},{"nctId":"NCT01050374","phase":"NA","title":"Safety and Efficacy of Drug Combinations Against Schistosomiasis","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","startDate":"2007-10","conditions":"Parasitic Diseases","enrollment":650},{"nctId":"NCT01050517","phase":"NA","title":"Safety and Efficacy of Drug Combinations Against Triple Infections","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","startDate":"2007-10","conditions":"Parasitic Diseases","enrollment":250}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":220,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Albendazole","Praziquantel","ABZ+PZQ","ABZ+PZQ PCB"],"phase":"marketed","status":"active","brandName":"albendazole and praziquantel","genericName":"albendazole and praziquantel","companyName":"R-Evolution Worldwide S.r.l. Impresa Sociale","companyId":"r-evolution-worldwide-s-r-l-impresa-sociale","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Albendazole and praziquantel are anthelmintic agents that disrupt microtubule formation and calcium homeostasis in parasitic worms, leading to their paralysis and death. Used for Helminthic infections (roundworms, tapeworms, flukes), Polyparasitic infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}